Home › Marginal Zone Lymphoma › Georgia › Atlanta
Marginal Zone Lymphoma clinical trials in Atlanta, GA
5 studies for Marginal Zone Lymphoma are looking for participants at sites in and around Atlanta (within about 30 miles). Open a study to see who can join and how to contact the study team.
Open-label of Loncastuximab Tesirine (ADCT-402) in Relapsed/Refractory Marginal Zone Lymphoma
RecruitingPhase 2
- Emory University, Atlanta
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
RecruitingPhase 1
- Winship Cancer Institute of Emory University, Atlanta
SynKIR-310 for Relapsed/Refractory B-NHL
RecruitingPhase 1
- Winship Cancer Institute of Emory University, Atlanta
Acalabrutinib and Obinutuzumab for the Treatment of Previously Untreated Follicular Lymphoma or Other Indolent Non-Hodgkin Lymphomas
RecruitingPhase 2
- Emory University Hospital/Winship Cancer Institute, Atlanta
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Atlanta
Marginal Zone Lymphoma trials in other cities
- Durham, NC12 studies
- New York City, NY11 studies
- Seattle, WA9 studies
- Milwaukee, WI9 studies
- Boston, MA9 studies
- Baldwin Park, CA8 studies
- Columbus, OH8 studies
- Houston, TX8 studies
- Rochester, MN8 studies
- Edison, NJ8 studies
- Denver, CO7 studies
- Miami, FL7 studies
Other studies in Atlanta
- Cancer (all types)50 studies
- Non-Small Cell Lung Cancer46 studies
- Breast Cancer41 studies
- Multiple Myeloma41 studies
- Prostate Cancer32 studies
- Colorectal Cancer29 studies
- Lung Cancer29 studies
- Ovarian Cancer28 studies
- Acute Myeloid Leukemia28 studies
- Obesity27 studies
- Metastatic Cancer27 studies
- Heart Failure25 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.